Aurobindo Pharma Ltd updates on pre-approval inspection

Aurobindo Pharma Ltd has announced that the Pre-approval inspection was carried out during the period 8th Feb '22 to 15th Feb '22. On completion of the inspection, Form 483 was issued with 5 observations. Based on the inspection review and the written responses provided by the Company, the Agency has concluded that the assessment is completed with 'no remaining deficiencies'.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 536.05 as compared to the previous close of Rs. 550.75. The total number of shares traded during the day was 74149 in over 3579 trades.

The stock hit an intraday high of Rs. 554.95 and intraday low of 534.00. The net turnover during the day was Rs. 40089098.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 USFDA Inspection Updates